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While advancements have been made in some areas of pathology with diagnostic materials being screened using image analysis
technologies, the reporting of cultures from agar plates remains a manual process. We compared the results for 2,163 urine cul-
tures read by a reference panel of microbiologists, by the routine laboratory process, and by an automated plate reading system,
APAS (LBT Innovations Ltd., South Australia). APAS detected colonies with a sensitivity of 99.1% and a specificity of 99.3% on
blood agar, while on MacConkey agar, the colony detection sensitivity was 99.4% with a specificity of 99.3%. The device’s ability
to enumerate growth had an accuracy of 89.2%, and the morphological identification of colonies showed a high level of perfor-
mance for the colony types typical of Escherichia coli and other enteric bacilli. On blood agar, lactose-fermenting colonies were
morphologically identified with a sensitivity of 98.9%, while on MacConkey agar they were identified with a sensitivity of 99.2%.
In this first clinical evaluation, APAS demonstrated high performance in the detection, enumeration, and colony classification of
isolates compared with that for conventional plate-reading methods. The device found all cases reported by the laboratory and
detected the most commonly encountered organisms found in urinary tract infections.
Traditional culture techniques and the use of agar plates remainimportant tools in the identification of bacterial infections and
are still in common use within the field of diagnostic microbiol-
ogy. In other areas of the clinical laboratory, a combination of
diagnostically effective screening tests and automation has led to
improvements in throughput, precision, data handling, and pa-
tient safety (1, 2). These technologies are now assisting laborato-
ries in meeting the many challenges being faced by diagnostic
facilities around the world.
While automated specimen, plate handling, and plate imaging
devices are now being introduced into the microbiology labora-
tory (3, 4), the reporting of cultures has remained a predomi-
nantly manual process. This contrasts with technologies now
routinely applied within diagnostic devices in the fields of cytopa-
thology and hematology (5, 6) where some prescreening using
image analysis technologies has been introduced to streamline
workflow and produce efficiencies.
APAS (LBT Innovations Ltd., South Australia) is an image
analysis device dedicated to screening agar plates for growth. It is
able to detect colonies, enumerate the various colony types pres-
ent, and, with use of an interpretive algorithm, apply standard
rules to assign each plate and case into convenient categories for
further processing.
As infections of the urinary tract are common (7) and contrib-
ute to a significant proportion of the effort and resource use
within clinical microbiology laboratories (8, 9, 10, 11, 12), the
performance of APAS was assessed against the traditional manual
reading method for culture plates inoculated with urine.
MATERIALS AND METHODS
Specimens. Clean catch and catheter urine samples submitted for routine
cultures to a clinical laboratory (Healthscope Pathology, Wayville, South
Australia) over a 4-week period were included in the study. Referrals were
sourced from community clinics and hospitals with a variety of age groups
and clinical presentations represented. Specimens were collected in com-
pliance with the laboratory’s protocols, stored under laboratory con-
trolled conditions, and tested on the day of receipt.
Instrumentation. The APAS system used in this study consisted of a
plate-handling mechanism, a lighting module, a digital camera, and ana-
lytical software. A high-quality monitor linked to the system was used for
reviewing digital plate images.
From each digital image, the device estimated the total colony numbers
and converted these to a CFU per milliliter value appropriate to the 1-l
inoculum used in this study. All colonies detected by the device were differ-
entiated into one of the morphology groups listed in Table 1. Differentiation
was based on the physical characteristics and color reactions associated with
the agar formula, with the groupings designed as a guide for interpretation
and not as a replacement for formal identification procedures.
Additional information such as operator alerts for critical specimens and
positive complementary tests can be used by the device for consideration
within the decision algorithm. In this study, urine leukocyte counts per-
formed by the laboratory were uploaded to APAS from the laboratory’s in-
formation system and used to screen for cases of sterile pyuria.
The image analysis and leukocyte counts were collated by the device,
and an interpretive algorithm was applied using rules based on published
guidelines (13, 14). Cases were then segmented by the device into one of
three groups: “positive” for plates requiring further work, “negative” for
plates with a low probability of requiring further work, and “review”
where an on-screen assessment by a microbiologist was required before a
workflow or reporting decision was made.
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All results were presented for on-screen review and electronically
transferred to a database. Each report included the enumeration of growth
and a summary of the colony morphologies present.
Culture and processing. Urine cultures were prepared by inoculating 1
l of well-mixed urine onto standard 90-mm plates of trypticase soy agar with
sheep blood and MacConkey agar with crystal violet (Remel, Lenexa, KS,
USA). The plates were incubated aerobically for 18 h at 35°C.
Following incubation, a reference panel of three experienced micro-
biologists independently and outside the routine workflow recorded the
amount of growth and the colony morphologies found on the plates. The
growth enumeration was estimated for the 1-l inoculum and recorded in
CFU per milliliter, while the colony morphologies present on each plate
were reported as described in Table 1. A fourth microbiologist presented
the plates to APAS for imaging and analysis.
The urine leukocyte counts obtained by the laboratory’s standard
method were electronically transferred to the device for use within the
decision algorithm. A pyuria flag, defined as 50  103 leukocytes/ml,
was used by the device to indicate possible cases of sterile pyuria. These
cases were then reported by APAS as requiring further review by a micro-
biologist if growth was not detected.
Results generated by the laboratory from the routine workflow for the
urine samples enrolled in the study were filed for comparison with the
APAS results.
Analysis. An independent statistician (Emphron Informatics Pty Ltd.,
Brisbane, Australia) analyzed the results by comparing the APAS findings
with the consensus results from the reference panel. Where differences in
individual panel member reports were present, a majority finding was used.
Performance values for growth detection, enumeration, and the dif-
ferentiation of colony morphologies using sensitivity and specificity cal-
culations were obtained. Sensitivity was defined as the number of true
positives divided by the number of true positives plus false negatives ex-
pressed as a percentage, and specificity was the number of true negatives
divided by the number of true negatives plus false positives and expressed
as a percentage.
APAS and the reference panel interpreted the results by the application
of published guidelines (13, 14).
An additional analysis was also performed to assess the ability of APAS
to detect specific uropathogens. This was done by comparing the results
from the device with the final reports issued by the laboratory.
RESULTS
Study participants and specimens. A total of 2,163 urine samples
from predominantly community-based patients, including 1,466
(68%) females and 697 (32%) males were examined in the study. The
ages of the patients were diverse with 206 (9.5%) 20 years, 461
(21.3%) from 21 to 40 years, 398 (18.4%) from 41 to 60 years, 661
(30.6%) from 61 to 80 years, and 437 (20.2%) 80 years. Of the urine
samples cultured, 2,156 (99.7%) were collected by the clean catch
method and the remaining 7 (0.3%) by catheter.
Growth detection. Colonies were detected by APAS on 1,603/
1,618 blood agar plates reported by the reference panel as having
growth and on 866/871 of the MacConkey agar plates. For blood agar,
this resulted in a growth detection sensitivity of 99.1% and a specific-
ity of 99.3%, while the performance for MacConkey agar showed a
growth detection sensitivity of 99.4% and a specificity of 99.3%.
Differences between the device’s ability to detect colonies at
various growth levels were noted. At 105 CFU/ml, the colony de-
tection sensitivity for blood agar was 100%, while at 104 CFU/ml
and 103 CFU/ml, the sensitivities were 99.6% and 96.8%, respec-
tively. For MacConkey agar, the differences were less marked, with
detection sensitivities of 100% at 105 CFU/ml, 99.4% at 104 CFU/
ml, and 97.9% at 103 CFU/ml.
On 15 blood agar plates where growth was reported by the
reference panel but not by APAS, small numbers of colonies of
0.4-mm diameter at 103 and 104 CFU/ml were observed follow-
ing technologist review of the images.
Growth enumeration. The reference panel determined 450 cases
with no growth, 413 with 103 CFU/ml, 492 with 104 CFU/ml, and 728
with 105 CFU/ml. For the purposes of comparison, 80 of the 2,163
cases were removed because APAS was unable to enumerate growth
in the presence of moderate to high numbers of swarming colonies
such as Proteus mirabilis. In such instances, these cases were re-
ferred by the device for review and definitive enumeration and
assessment by a microbiologist.
APAS produced the correct enumeration in 1,859/2,083
(89.2%) of the remaining cases with differences in agreement
noted at the various growth levels: 96.7% at 105 CFU/ml, 77% at
104 CFU/ml, 88.6% at 103 CFU/ml, and 91.1% at 0 CFU/ml.
Of the 224 enumeration discrepancies, APAS determined that
138 were greater than and 86 were less than the values reported by
the reference panel, and 204 were within 1 log of the reference
panel’s consensus count.
Colony morphologies. A number of different colony mor-
phologies were identified by APAS, and the performance for each
is listed in Table 1. For key urinary tract infection (UTI) pathogens
on blood agar, coliform-like and swarming colonies (e.g., Proteus
mirabilis) were identified with sensitivities of 98.9% and 97.2%
and specificities of 83.9% and 99.9%, respectively. On MacCon-
key agar, lactose fermenters were identified with a sensitivity of
99.2% and a specificity of 98.1%.
Examples of the ability to differentiate colonies can be seen in
the images found in Fig. 1 to 4.
Segmentation of cases. All 509 cases reported by the labora-
tory with significant growth were segmented as either positive or
review by APAS and produced a segmentation sensitivity of 100%.
A further 818 cases segmented as positive or review were reported
TABLE 1 Colony identification performance by APAS compared with that of a reference panel
Colony morphologies on blood agar Examples of colony morphology Sensitivity (%) Specificity (%)
Coliform-like colonies Escherichia coli 98.9 83.9
Swarming colonies Proteus mirabilis 97.2 99.9
Granular Gram-negative colonies Pseudomonas aeruginosa 67.7 92.5
Staphylococcus-like colonies Staphylococcus spp. 94 83.8
Small beta-hemolytic colonies Streptococcus agalactiae 92.4 89.3
Small colonies Enterococci, lactobacilli, corynebacteria 90 73.7
Colony morphologies on MacConkey agar
Lactose fermenters Escherichia coli 99.2 98.1
Non-lactose fermenters Proteus spp. 92.6 95.9
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by the laboratory as not having significant growth and contributed
to the specificity of 66.9%.
If the leukocyte counts had not been included in the interpre-
tive algorithm, the device would have found 506/509 cases and
produced a segmentation sensitivity of 99.4%.
Organisms reported by the laboratory. Growth of potentially
significant organisms were reported by the laboratory from 509/
2,163 (23.5%) specimens submitted. The most common patho-
gens were Escherichia coli (n  341), Enterococcus faecalis (n  38),
Klebsiella pneumonia (n  21), Proteus mirabilis (n  19), and
FIG 1 Image of a blood agar plate following inoculation with urine and incu-
bation for 18 h at 35°C that shows mixed growth of a Gram-negative bacillus
and Gram-positive coccus.
FIG 2 APAS computer interpretation of mixed growth of a Gram-negative
bacillus (red) and Gram-positive coccus (black) from the blood agar plate
shown in Fig. 1.
FIG 3 Image of a MacConkey agar plate following inoculation with urine and
incubation for 18 h at 35°C that shows mixed growth of lactose- and non-
lactose-fermenting colonies.
FIG 4 APAS computer interpretation of mixed growth of lactose-fermenting
colonies (red) and non-lactose-fermenting colonies (black) from the Mac-
Conkey agar plate shown in Fig. 3.
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Pseudomonas aeruginosa (n  19) (Table 2). Less frequently en-
countered isolates, including 3 cases of infection due to viridans
streptococci, 3 cases of Candida spp. (including Candida albi-
cans), and 1 case of Aerococcus urinae, were also reported.
Cases referred for review. During the study, APAS referred
374/2,163 (17.3%) cases for onscreen review by a microbiologist.
Of these, 256 cases were due to the presence of low numbers of
coliform-like or lactose-fermenting colonies and a further 80 cases
were referred for review because the device identified the presence
of swarming colonies on blood agar. The remaining cases were
referred for review because of the possible presence of a mixture of
potential pathogens at a concentration of 104 CFU/ml.
DISCUSSION
Two measures were used to define the performance of this novel
device during the study. The reference panel provided a consensus
result for the enumeration and description of growth, while the
final reports issued by the laboratory allowed comparisons to be
made to ensure that APAS identified all significant instances of
growth.
The organisms isolated during the study were representative of
those found in urinary tract infections from community and hos-
pitalized patients (15, 16, 17, 18). In this study, E. coli, Enterococcus
faecalis, Klebsiella pneumonia, Proteus mirabilis, Pseudomonas
aeruginosa, and Staphylococcus saprophyticus were the most com-
monly encountered organisms and represented 88.5% of the total
isolates reported.
Growth was found by the reference panel and not by APAS on
15/1,618 blood agar and 5/871 MacConkey agar plates. On review,
the colonies not captured by APAS on blood agar were seen on the
images as having diameters of 0.4 mm and were present in con-
centrations of 103 and 104 CFU/ml. They were considered to be
normal skin and urogenital organisms such as lactobacilli and
corynebacteria. Colonies missed on MacConkey agar were small,
partially suppressed nonfermenters.
This finding led to the conclusion that some small colonies and
perhaps the early growth stages of slow-growing pathogens such
as Aerococcus urinae and Corynebacterium urealyticum might be
missed by APAS if cultures are only incubated for 18 h on the
media used in this study. The consequence of this observation is
that cases of complicated urinary tract infection, where slow-
growing organisms may be expected, will need to be carefully
managed by following established guidelines, including the inoc-
ulation of higher specimen volumes and additional culture media
as well as the extension of incubation times (13).
The identification of colony morphologies showed a high level
of performance. For morphologies representing E. coli and the
other enteric bacilli on blood agar, an identification sensitivity of
98.9% was obtained, while on MacConkey agar, lactose-ferment-
ing colonies were identified with a sensitivity of 99.2%. The colony
morphology classed as “granular Gram-negative colonies” pro-
duced the lowest performance with a sensitivity of 67.7%. This
category of colonies represented the classic large, rough colony
type of Pseudomonas aeruginosa. When these colonies were as-
sessed by APAS, they were generally categorized as coliform-like
colonies, and the cases were redirected for a microbiologist’s re-
view. The result was that this type of misclassification did not
compromise the overall interpretation and patient safety. This
assigned morphology discrepancy is not dissimilar to the general
practices of trained microbiologists, who may at times make sub-
jective colony morphology classifications before full identification
procedures are initiated.
A total of 818 cases found to be positive by APAS were reported
by the laboratory as having either contaminants or normal uro-
genital flora present where typically greater than three organisms
were present. This false-positive rate was responsible for the low
specificity of 66.9%. However, as each of these cases was referred
by APAS to a microbiologist for careful review in line with the
laboratory’s interpretive criteria, patient safety was not compro-
mised. Thus, as a screening device, where sensitivity is more im-
portant than specificity (19), the segmentation of these cases by
APAS was favorable and as such was considered acceptable within
the general workflow of a modern laboratory.
The urine leukocyte count was used within the APAS decision
algorithm for each specimen within the study. This optional fea-
ture identified three cases with apparently sterile pyuria. Further
assessment of these cases by the laboratory showed that clinically
relevant growth was detected on cultures inoculated with 10 l
urine as opposed to the 1 l used in the study. Associating leuko-
cyte counts with the culture report can enhance the diagnostic
value of urine cultures as the finding of pyuria may indicate the
presence of low numbers of uropathogens, slow-growing organ-
isms, or more complex urinary tract pathology (13, 20, 21).
The recent introduction of plate-imaging systems for reading
cultures offers a number of quality improvements and an image









Escherichia coli 339 341
Enterococcus faecalis 38 38
Klebsiella pneumoniae 21 21
Proteus mirabilis 19 19
Pseudomonas aeruginosa 18 19
Staphylococcus saprophyticus 14 14
Klebsiella oxytoca 8 8
Staphylococcus epidermidis 7 7
Streptococcus agalactiae 6 6
Enterobacter aerogenes 5 5
Citrobacter koseri 5 5
Enterobacter cloacae complex 3 3
Morganella morganii 3 3
Viridans streptococci 3 3
Candida albicans 2 2
Citrobacter freundii 2 2
Staphylococcus, coagulase negative 2 2
Acinetobacter spp. 1 1
Aerococcus urinae 1 1
Candida spp. 1 1
Enterococcus faecium 1 1
Raoultella spp. 1 1
Serratia liquefaciens 1 1
Serratia ureilytica 1 1
Staphylococcus aureus 1 1
Staphylococcus haemolyticus 1 1
Staphylococcus hominis 1 1
Streptococcus dysgalactiae 1 1
Total 506 509
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archive facility for diagnostic and teaching purposes (3, 4). Pro-
gressing from these imaging systems to fully automated culture
plate readers will be challenging as there is a perception that ma-
chines cannot exercise the complex decision-making skills re-
quired to assess microbiological cultures (3). Additionally, little
has been published regarding the accuracy and reproducibility of
manual plate reading, so validating new technologies will require a
better understanding of current manual reporting performances.
In conclusion, all cases of clinical infection were detected by
APAS and its associated decision algorithm during the study.
However, in a few cases, small colonies in low numbers were not
detected, indicating the possibility that uropathogens in the early
stage of growth or highly fastidious organisms may not be de-
tected. To avoid this, specimen management and result validation
strategies as described above may need to be implemented.
The introduction of automated plate assessment systems is
likely to facilitate the rationalization of resources in the clinical
laboratory and lead to workplace efficiencies and improved staff
and patient safety through the reduction in plate handling and
transcription of results. Furthermore, the screening of a large por-
tion of samples as “negative” will allow experienced staff to use
their time and skills for reviewing complex cases.
Such systems, as described here, will allow better segrega-
tion of tasks and use of skilled staff and will be a welcome
addition to the routine clinical microbiology laboratory. Fur-
ther studies are currently planned to assess and refine this new
technology for routine use.
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